AI assistant
CLEO DIAGNOSTICS LTD — Major Shareholding Notification 2026
Jan 4, 2026
64689_rns_2026-01-04_421d71b6-9001-4a75-b70e-3cda06a64e4d.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
605[page1/2][15July2018]
Form 605
Corporations Act 2001 Section 671B
Notice of ceasing to be a substantial holder
To Company/registered scheme/notified foreign passport fund name CLEO DIAGNOSTICS LIMITED ACN/ARSN/APFRN 655 717 169 NFPFRN (if applicable) Not Applicable
1. Details of substantial holder (1)
Name HUDSON INSTITUTE INVESTMENT HOLDINGS PTY LTD ACN/ARSN/APFRN (if applicable) 641 773 159 NFPFRN (if applicable) Not Applicable
The holder ceased to be a substantial holder on 29 / 12 / 2025 The previous notice was given to the company, or the responsible entity for a registered scheme, or the operator of a notified foreign passport fund on / / The previous notice was dated / /
2. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company, scheme or fund, since the substantial holder was last required to give a substantial holding notice to the company, scheme or fund are as follows:
see attached Annexure A
| Date of change |
Person whose relevant interest changed |
Nature of change(4) |
Consideration given in relation to change (5) |
Class (6) and number of securities affected |
Person's votes affected |
|---|---|---|---|---|---|
3. Changes in association
The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting securities in the company, scheme or fund are as follows:
| Name and ACN/ARSN/APFRN (if applicable) and NFPFRN (if applicable) |
Nature of association |
|---|---|
4. Addresses
The addresses of persons named in this form are as follows:
| Name | Address |
|---|---|
| ROBERT MERRIEL | 3 EVERTON GROVE,SURREY HILLS,VIC,3127 |
Signature
print name
ROBERT MERRIEL
capacity DIRECTOR
==> picture [48 x 33] intentionally omitted <==
sign here
date / 05/01/2026 /
605[page 2/2 15July 2018 ]
DIRECTIONS
-
(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.
-
(2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
-
(3) See the definition of "associate" in section 9 of the Corporations Act 2001.
-
(4) Include details of:
-
(a) Any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
-
(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
-
(5) Details of the consideration must include any and all benefits, money or otherwise, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
-
(6) The voting shares of accompany constitute one class unless divided into separate classes.
-
(7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
ANNEXURE A
Detail for Form 605 HUDSON INSTITUTE INVESTMENT HOLDINGS PTY LTD - ACN 641 773 159
| **Date of Change ** | Person whose relevant interest changed | Nature of Change | Consideration | Consideration | Class of Securities | Number of Shares |
Person's votes affected |
|---|---|---|---|---|---|---|---|
| 1/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 155.12 |
Ordinary fully paid shares | 383 | Hudson Institute Investment Holdings |
| 1/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 6,300.00 |
Ordinary fully paid shares | 15,000 | Hudson Institute Investment Holdings |
| 1/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 7,387.41 |
Ordinary fully paid shares | 17,485 | Hudson Institute Investment Holdings |
| 2/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 1,861.60 |
Ordinary fully paid shares | 4,654 | Hudson Institute Investment Holdings |
| 4/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 20,545.60 |
Ordinary fully paid shares | 51,364 | Hudson Institute Investment Holdings |
| 4/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 658.09 |
Ordinary fully paid shares | 1,635 | Hudson Institute Investment Holdings |
| 4/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 319.80 |
Ordinary fully paid shares | 780 | Hudson Institute Investment Holdings |
| 7/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 16,496.40 |
Ordinary fully paid shares | 41,241 | Hudson Institute Investment Holdings |
| 7/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 10,125.00 |
Ordinary fully paid shares | 25,000 | Hudson Institute Investment Holdings |
| 7/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 41.41 |
Ordinary fully paid shares | 101 | Hudson Institute Investment Holdings |
| 23/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 158.40 |
Ordinary fully paid shares | 396 | Hudson Institute Investment Holdings |
| 24/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 34,043.20 |
Ordinary fully paid shares | 85,108 | Hudson Institute Investment Holdings |
| 25/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 7,798.40 |
Ordinary fully paid shares | 19,496 | Hudson Institute Investment Holdings |
| 30/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 3,286.80 |
Ordinary fully paid shares | 8,217 | Hudson Institute Investment Holdings |
| 31/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 6,713.20 |
Ordinary fully paid shares | 16,783 | Hudson Institute Investment Holdings |
| 31/07/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 9,402.89 |
Ordinary fully paid shares | 23,217 | Hudson Institute Investment Holdings |
| 29/08/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 12,950.00 |
Ordinary fully paid shares | 35,000 | Hudson Institute Investment Holdings |
| 8/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 17,609.78 |
Ordinary fully paid shares | 47,594 | Hudson Institute Investment Holdings |
| 8/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 18,750.00 |
Ordinary fully paid shares | 50,000 | Hudson Institute Investment Holdings |
| 10/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 15,000.00 |
Ordinary fully paid shares | 40,000 | Hudson Institute Investment Holdings |
| 9/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 30,062.02 |
Ordinary fully paid shares | 81,546 | Hudson Institute Investment Holdings |
| 10/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 24,375.00 |
Ordinary fully paid shares | 65,000 | Hudson Institute Investment Holdings |
| 10/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 3,775.00 |
Ordinary fully paid shares | 10,000 | Hudson Institute Investment Holdings |
| 10/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 72,915.54 |
Ordinary fully paid shares | 191,883 | Hudson Institute Investment Holdings |
| 10/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 33,925.05 |
Ordinary fully paid shares | 88,117 | Hudson Institute Investment Holdings |
| 11/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 6,650.00 |
Ordinary fully paid shares | 17,500 | Hudson Institute Investment Holdings |
| 11/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 9,625.00 |
Ordinary fully paid shares | 25,000 | Hudson Institute Investment Holdings |
| 12/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 3,850.00 |
Ordinary fully paid shares | 10,000 | Hudson Institute Investment Holdings |
| 12/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 3,630.90 |
Ordinary fully paid shares | 9,555 | Hudson Institute Investment Holdings |
| 12/09/2025 | Hudson Institute Investment Holdings | On Market sale | $ | 6,729.38 |
Ordinary fully paid shares | 17,945 | Hudson Institute Investment Holdings |
| $ | 385,140.97 |
1,000,000 | |||||
| **Date of Change ** | Person whose relevant interest changed | Nature of Change | Consideration | Class of Securities | Number of Shares |
Person's votes affected | |
| Dilution from issue of shares | |||||||
| 29/12/2025 | Hudson Institute Investment Holdings | under a thrid party placement | $ | - |
Ordinary fully paid shares | 6,500,000 | Hudson Institute Investment Holdings |
| by Cleo Diagnostics Ltd |
==> picture [74 x 50] intentionally omitted <==
05/01/2026
This is Annexure A of 3 pages referred to in form 605 Notice of ceasing to be a substantial holder